Lower Urinary Tract Symptoms
Conditions
Keywords
Lower Urinary Tract Symptoms, Multiple Sclerosis, Pelvic Floor Muscle Training
Brief summary
The aim of this study was to investigate the effects of digital pelvic floor muscle training and lifestyle recommendations in patients with Multiple Sclerosis having lower urinary tract symptoms.
Detailed description
Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system. Lower urinary tract symptoms (LUTS) are very common in MS. Pelvic floor muscle training (PFMT) is one of the first-line choices for the conservative treatment of LUTS. According to our knowledge, no study has investigated the effects of digital pelvic floor muscle training and lifestyle recommendations in MS having LUTS, yet.
Interventions
OTHERExercise
Pelvic floor muscle training program planned under the supervision of a physiotherapist was applied and followed to the exercise group, using the digital application.
Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms
Sponsors
Ataturk Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Participants will be randomly divided into two groups (control and exercise) for treatment.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Having a diagnosis of MS and having at least two of the lower urinary symptoms * Not having an attack in the last 1 month, * No change in medical treatment in the last 3 months * Expanded disability status scale-EDSS score is less than 6.5 * Not having any cognitive problems that would hinder cooperation and understanding * Those who use digital devices such as computers, laptops, smartphones and tablets * Volunteering to participate in the study
Exclusion criteria
* Pregnancy status * Active urinary tract infection * Another neurological disease that can cause incontinence * A history of malignancy * Prostate surgery * Those with missing evaluation parameters * Those who do not regularly participate in treatment programs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incontinence symtoms | change from baseline at 8 weeks | Urinary incontinence symptoms will be evaluated with The International Consultation of Incontinence Questionnaire - Short Form |
| Overactive bladder symptoms | change from baseline at 8 weeks | Overactive bladder symptoms will be evaluated with Overactive Bladder Questionnaire-Version8 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| bladder functions | change from baseline at 8 weeks | bladder functions will be evaluated with voiding diary |
| Quality of life level | change from baseline at 8 weeks | Quality of life will be evaluated with King's Health Questionnaire |
| subjective perception of improvement | after treatment (8th week) | subjective perception of improvement will be evaluated with a 4-item Likert-type scale |
| patient satisfaction | after treatment (8th week) | patient satisfaction will be evaluated with a 5-item Likert-type scale |
Countries
Turkey (Türkiye)
Contacts
Primary ContactSeyda Toprak Celenay
Outcome results
None listed